Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $405.80 thousand as of June 16, 2025. Its market cap has decreased by -87.42% in one year.

Market Cap

405.80K

Enterprise Value

-231.77K

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.07

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 405.80K, a decrease of -99.76%. That is a compound annual growth rate of -42.72%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	405.80K	7.96%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	29.91M	459.11%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Veradigm	764.23M
Elite Pharmaceuticals	717.88M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
CytoDyn	441.29M
Northwest Biotherapeutics	403.72M
Glass House Brands	384.13M

Market Cap Rankings